Healthcare
Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
Company Strengthens IP Portfolio and Prepares for EB-003 IND Submission
Eli Lilly Strikes $2.75 Billion AI Drug Discovery Deal With InSilico
The partnership aims to leverage InSilico's AI-powered drug development capabilities to create new treatments across multiple therapeutic areas.
Business Insurance Health Announces Plan Quality Analyzer
New tool will score plan designs, project HRA costs, and benchmark employer competitiveness against peers
- Early College Programs Expand Access to Higher Ed
- Massachusetts DA Criticizes Parole Board's Decision to Free Convicted Killer
- US Navy Commissions New Nuclear-Powered Submarine in Boston Harbor
- Jayson Tatum, short-handed Celtics handle Hornets
- Young Latter-day Saints in Massachusetts Strengthen Faith and Community
- Vice President Wilson's Funeral Procession Mourned in Boston
